GO
Loading...

Medicine

More

  • New discovery in $1.7 billion IVF business     Thursday, 17 Apr 2014 | 2:57 PM ET

    CNBC's Meg Tirrell reports on a new scientific discovery for the more than $1.7 billion U.S. business of in vitro fertilization. Robert Frank provides insight.

  • April 17- The U.S. Food and Drug Administration warned that a surgical procedure used to mince uterine fibroids and remove them through a tiny abdominal incision could spread cancer tissue beyond the uterus in women with undetected uterine cancer.

  • FDA warns of cancer risk with fibroid procedure Thursday, 17 Apr 2014 | 1:05 PM ET

    WASHINGTON— The Food and Drug Administration is warning women that a surgical procedure used to eliminate growths in the uterus could inadvertently spread cancer to other parts of the body.

  • April 17- UnitedHealth Group Inc, the largest U.S. health insurer, said on Thursday it has spent more than $100 million to cover a pricey new hepatitis C drug from Gilead Sciences Inc, a higher cost than it expected by "multiples," sending shares in the sector lower.

  • New kind of trial aims to speed cancer drug development Wednesday, 16 Apr 2014 | 7:01 PM ET

    *AstraZeneca, Pfizer, UK charity link in multi-drug trial. Instead of testing one drug at a time, a novel lung cancer study announced on Thursday will allow British researchers to test up to 14 drugs from AstraZeneca and Pfizer at the same time within one trial.

  • Kansas to mandate some health coverage on autism Wednesday, 16 Apr 2014 | 5:01 AM ET

    OVERLAND PARK, Kan.— Kansas will require health insurance companies to cover services for hundreds of children with autism starting next year under a bill signed into law Wednesday by Gov. Brownback signed the bill in an auditorium on the satellite University of Kansas campus in Overland Park, the home of a center for autism research.

  • FDA approves injectable diabetes drug from Glaxo Tuesday, 15 Apr 2014 | 3:08 PM ET

    WASHINGTON— The Food and Drug Administration said Tuesday it approved a new injectable drug from GlaxoSmithKline plc for adults with Type 2 diabetes. The FDA said it approved the new drug based on eight trials including more than 2,000 patients.

  • Americans start spending on health care again Tuesday, 15 Apr 2014 | 7:06 AM ET

    Americans used more health services and spent more on prescription drugs in 2013, reversing a recent trend.

  • ZURICH, April 15- A strong uptake of new cancer medicines helped Roche to limit a decline in first-quarter sales and the Swiss company confirmed a forecast for higher earnings this year.

  • *Q1 sales 11.496 bln Swiss francs vs 11.887 bln forecast. ZURICH, April 15- Adverse currency moves weighed on first-quarter sales at Roche Holding AG, which fell 1 percent, despite a healthy uptake of its new cancer medicines.

  • Google Glass helps doctor save a life Monday, 14 Apr 2014 | 1:05 PM ET
    A man wearing Google Glass at the headquarters of Google Belgium in Brussels.

    Google Glass might have another purpose than just entertaining. Dr Horng from Boston said that it helped saved a patient's life last January.

  • NEW YORK, April 14- There are many enterprises out there trying to separate you from your tax refund- from splurges such as airlines tickets for a celebratory vacation or for good purposes, like putting it all in a college savings account.

  • How Google Glass helped save a life     Monday, 14 Apr 2014 | 11:43 AM ET

    Dr. Steven Horng, Beth Israel Deaconess Medical Center, explains how Google Glass provided crucial support in an emergency situation and helped save a life.

  • April 14- Lexicon Pharmaceuticals Inc said its experimental drug to treat diabetes met the main goal of reducing the use of insulin at meal times in a mid-stage study on patients with type 1 diabetes. The company's shares rose 19.5 percent to $1.90 in trading before the bell.

  • April 14- Lexicon Pharmaceuticals Inc said its experimental drug to treat diabetes met the main goal of reducing the use of insulin at meal times in a mid-stage study on patients with type 1 diabetes. The company's shares rose about 19 percent to $1.89 in trading before the bell.

  • April 12- A drug being developed by Intercept Pharmaceuticals Inc led to significant improvement in signs of a rare liver disease that primarily affects middle-aged women, likely reducing the risk of need for liver transplant and of death, according to results of a late-stage clinical trial presented on Saturday.

  • LOS ANGELES/ LONDON April 11- Doctors at a key medical conference welcomed the prospect of more new drugs to treat the liver-destroying hepatitis C virus, while agreeing that Gilead Sciences Inc continues to lead the effort.

  • Mexican police issue 'ransom ware' virus warning Thursday, 10 Apr 2014 | 4:44 PM ET

    MEXICO CITY— Police in Mexico City have issued a warning about a new type of "ransom ware" virus that can take over computers' cameras and make the user think they are under surveillance. The Mexico City police department's cyber-crime unit says the virus infects computers, generally after they view or download sexually explicit material.

  • Hep C breakthrough     Thursday, 10 Apr 2014 | 2:53 PM ET

    CNBC contributor Barbara Ryan provides insight into new guidelines from the World Health Organization, which strongly endorses two new hepatitis c drugs.

  • WASHINGTON, April 10- The leading U.S. pharmaceutical industry trade group on Thursday defended the cost of Gilead Sciences Inc's new hepatitis C drug, Sovaldi, saying such treatments offer a priceless breakthrough for patients with the liver-destroying virus.

Most Popular Video

Monday, 14 Apr 2014 | 11:43 AM ET

Dr. Steven Horng, Beth Israel Deaconess Medical Center, explains how Google Glass provided crucial support in an emergency situation and helped save a life.

Tuesday, 15 Apr 2014 | 11:36 PM ET

John Sculley, former Apple CEO and Managing Partner at Inflexionpoint, expects Alibaba to push on with its buying spree after listing in the U.S.

Thursday, 17 Apr 2014 | 4:00 PM ET

On this week's "$ave Me," CNBC's Kelli Grant gives tips on how to finally earn enough for that free airline award seat.